A Study to Determine the Abuse Potential of Single Oral Doses of Lemborexant Compared to Zolpidem, Suvorexant and Placebo in Healthy, Non-Dependent, Recreational Sedative Users
CompletedNCT03158025
Eisai Inc.Insomnia Disorders
Start: 2017-04-19End: 2018-07-04Updated: 2020-06-29